Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Ultra-Sensitive mNGS, Real-Time PCR, Galactomannan, and Lateral-Flow Device for Diagnosing Invasive Fungal Disease in Lung Transplantation: A Retrospective Cross-Sectional Study

NCT06654076 is registered in ClinicalTrials.gov with Guangzhou Institute of Respiratory Disease as lead sponsor.

NCT NCT06654076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06654076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Ultra-Sensitive mNGS, Real-Time PCR, Galactomannan, and Lateral-Flow Device for Diagnosing Invasive Fungal Disease in Lung Transplantation: A Retrospective Cross-Sectional Study
Lead sponsor
Guangzhou Institute of Respiratory Disease
Phase
Observational
Overall status
Completed
Start date
January 1, 2015
Completion date
August 1, 2024
Enrollment
109 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

invasive fungal disease, invasive pulmonary aspergillosis, lung transplant recipients, pneumocystis jirovecii pneumonia